Aktie ACBM ACRO BIOMEDICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Acro Biomedical Co., Ltd.

Aktien

ACBM

US0048921052

ACBM

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:16:30 15.11.2023 		% 5 Tage % 1. Jan.
0.105 USD -.--% Intraday Chart für Acro Biomedical Co., Ltd. -.--% -.--%
2023 Acro Biomedical Co., Ltd. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2023 CI
2023 Acro Biomedical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
ACRO BIOMEDICAL CO., LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. ACBM Aktie
  4. Nachrichten Acro Biomedical Co., Ltd.
  5. Andere Sprachen